Pliant Therapeutics Announces Three Presentations At The Annual Meeting Of The Society For Immunotherapy Of Cancer
Portfolio Pulse from Benzinga Newsdesk
Pliant Therapeutics, Inc. (NASDAQ:PLRX) announced three presentations at the upcoming 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC). The presentations will cover selective targeting of integrins within pancreatic cancer, a Phase 1a trial of PLN-101095, and the expression of Integrin αvβ1 in multiple solid tumor types.
October 31, 2023 | 8:43 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pliant Therapeutics' presentations at the SITC meeting could potentially influence the perception of the company's ongoing research and development efforts.
The presentations at the SITC meeting will provide updates on Pliant Therapeutics' research and development efforts. While this could potentially influence investor sentiment, it's uncertain how the market will react to this news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100